Filing Details

Accession Number:
0001415889-24-025043
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-10-11 17:53:20
Reporting Period:
2024-10-09
Accepted Time:
2024-10-11 17:53:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1428336 Healthequity Inc. HQY () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1160228 W Robert Selander C/O Healthequity, Inc.
15 W. Scenic Pointe Dr., Ste. 100
Draper UT 84020
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-10-09 12,500 $28.68 60,469 No 4 M Direct
Common Stock Disposition 2024-10-09 1,504 $82.07 58,965 No 4 S Direct
Common Stock Disposition 2024-10-09 4,171 $83.27 54,794 No 4 S Direct
Common Stock Disposition 2024-10-09 75 $83.77 54,719 No 4 S Direct
Common Stock Acquisiton 2024-10-09 7,500 $21.27 62,219 No 4 M Direct
Common Stock Disposition 2024-10-09 752 $82.27 61,467 No 4 S Direct
Common Stock Disposition 2024-10-09 1,748 $83.34 59,719 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2024-10-09 12,500 $0.00 12,500 $28.68
Common Stock Stock Option (right to buy) Disposition 2024-10-09 7,500 $0.00 7,500 $21.27
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
37,500 2025-09-29 No 4 M Direct
7,500 2026-02-01 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on July 09, 2024.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.620 to $82.510, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2),(3),(4),(5) and (6) of this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.755 to $83.750, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $83.760 to $83.770, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $81.875 to $82.765, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.960 to $83.710, inclusive.
  7. The option is immediately exercisable.